Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Rotmensz

Showing results (71-80 of 100) with videos related to

Pageof 10
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Very young women (<35 years) with operable breast cancer: features of disease at presentationM Colleoni, N Rotmensz, C Robertson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trialR Biffi, F Orsi, S Pozzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large seriesU Veronesi, P Arnone, P Veronesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institutionO Gentilini, E Botteri, N Rotmensz, et al.
Ecancermedicalscience|January 26, 2012
Full-dose intra-operative radiotherapy with electrons (ELIOT) during breast-conserving surgery: experience with 1246 casesU Veronesi, R Orecchia, A Luini, et al.
Anticancer Research|August 19, 2007
Brain metastases in patients with advanced breast cancerG Sanna, L Franceschelli, N Rotmensz, et al.
Pageof 10

Showing results (71-80 of 100) with videos related to

Sort By:
Pageof 10
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 12, 2002
Very young women (<35 years) with operable breast cancer: features of disease at presentationM Colleoni, N Rotmensz, C Robertson, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 31, 2009
Best choice of central venous insertion site for the prevention of catheter-related complications in adult patients who need cancer therapy: a randomized trialR Biffi, F Orsi, S Pozzi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 2, 2012
Progesterone receptor loss identifies Luminal B breast cancer subgroups at higher risk of relapseG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 10, 2008
The value of radiotherapy on metastatic internal mammary nodes in breast cancer. Results on a large seriesU Veronesi, P Arnone, P Veronesi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 25, 2007
Prognostic role of the extent of peritumoral vascular invasion in operable breast cancerM Colleoni, N Rotmensz, P Maisonneuve, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 25, 2010
Prognosis and adjuvant treatment effects in selected breast cancer subtypes of very young women (<35 years) with operable breast cancerG Cancello, P Maisonneuve, N Rotmensz, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 21, 2014
Changes in PgR and Ki-67 in residual tumour and outcome of breast cancer patients treated with neoadjuvant chemotherapyE Montagna, V Bagnardi, G Viale, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 19, 2007
Is avoiding post-mastectomy radiotherapy justified for patients with four or more involved axillary nodes and endocrine-responsive tumours? Lessons from a series in a single institutionO Gentilini, E Botteri, N Rotmensz, et al.
Ecancermedicalscience|January 26, 2012
Full-dose intra-operative radiotherapy with electrons (ELIOT) during breast-conserving surgery: experience with 1246 casesU Veronesi, R Orecchia, A Luini, et al.
Anticancer Research|August 19, 2007
Brain metastases in patients with advanced breast cancerG Sanna, L Franceschelli, N Rotmensz, et al.
Pageof 10